Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic

AIDS and Behavior

Volumn 18, Issue 3, 2014, Pages 544-554

  Fletcher, Faith E ^a   Vidrine, Damon J ^a   Tami Maury, Irene ^a   Danysh, Heather E ^a   King, Rachel Marks ^a   Buchberg, Meredith ^a   Arduino, Roberto C ^b   Gritz, Ellen R ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cervical cancer screening; HIV positive female smokers; Multiple risk behavior; Pap smear screening; Smoking cessation program

Indexed keywords

ADULT; AGED; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS SCREENING; MIDDLE AGED; OUTPATIENT DEPARTMENT; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PREVALENCE; PSYCHOLOGICAL ASPECT; SMOKING; SOCIOECONOMICS; STATISTICS; UNITED STATES; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR; YOUNG ADULT;

ADULT; AGED; AMBULATORY CARE FACILITIES; EARLY DETECTION OF CANCER; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; MIDDLE AGED; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PREVALENCE; SMOKING; SOCIOECONOMIC FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 84896390439     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0480-6     Document Type: Article

References (86)

1. Ellerbrock TV, Chiasson MA, Bush TJ, Sun XW, Sawo D, Brudney K, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031-7.
2. Wright TC Jr, Ellerbrock TV, Chiasson MA, van Devanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol. 1994;84(4):591-7.
3. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277-84.
4. Strickler HD, Burk RD, Fazzari M, Anastos K, Minkoff H, Massad LS, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577-86.
5. Fruchter RG, Maiman M, Sedlis A, Bartley L, Camilien L, Arrastia CD. Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet Gynecol. 1996;87(3):338-44.
6. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2009;58(RR4):1-198.
7. Oster AM, Sullivan PS, Blair JM. Prevalence of cervical cancer screening of HIV-infected women in the United States. J Acquir Immune Defic Syndr. 2009;51(4):430-6.
8. Tello MA, Jenckes M, Gaver J, Anderson JR, Moore RD, Chander G. Barriers to recommended gynecologic care in an urban United States HIV clinic. J Womens Health (Larchmt). 2010;19(8):1511-8.
9. Tello MA, Yeh HC, Keller JM, Beach MC, Anderson JR, Moore RD. HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population. J Womens Health (Larchmt). 2008;17(10):1609-14.
10. Baranoski AS, Horsburgh CR, Cupples LA, Aschengrau A. Stier EA. J Womens Health (Larchmt): Risk Factors for Nonadherence with Pap Testing in HIV-Infected Women; 2011.
11. Dal Maso L, Franceschi S, Lise M, De Bianchi PS, Polesel J, Ghinelli F, et al. Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study. BMC Cancer. 2010;10:310.
12. Stein MD, Cunningham WE, Nakazono T, Turner BJ, Andersen RM, Bozzette SA, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr. 2001;27(5):463-6.
13. Rahangdale L, Sarnquist C, Yavari A, Blumenthal P, Israelski D. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. J Womens Health (Larchmt). 2010;19(4):709-12.
14. Leece P, Kendall C, Touchie C, Pottie K, Angel JB, Jaffey J. Cervical cancer screening among HIV-positive women. Retrospective cohort study from a tertiary care HIV clinic. Can Fam Physician. 2010;56(12):e425-31.
15. Keiser O, de Martinez B, Wunder D, Chapuis-Taillard C, Zellweger C, Zinkernagel AS, et al. Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study. J Acquir Immune Defic Syndr. 2006;43(5):550-5.
16. Logan JL, Khambaty MQ, D'Souza KM, Menezes LJ. Cervical cancer screening among HIV-infected women in a health department setting. AIDS Patient Care STDS. 2010;24(8):471-5.
17. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511-22.
18. Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71-7.
19. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care & STDs. 2002;16(1):39-42.
20. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV + men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371-83.
21. Goldberg D, Weber KM, Orsi J, Hessol NA, D'Souza G, Watts DH, et al. Smoking cessation among women with and at risk for HIV: are they quitting? J Gen Intern Med. 2010;25(1):39-44.
22. Henrica CWdV, Sturmans F, Knipschild PG. The role of cigarette smoking in the etiology of cervical dysplasia. Epidemiology. 1994;5(6):631-3.
23. Winkelstein W Jr. Smoking and cervical cancer-current status: a review. Am J Epidemiol. 1990;131(6):945-57 Discussion 58-60.
24. Lyon JL, Gardner JW, West DW, Stanish WM, Hebertson RM. Smoking and carcinoma in situ of the uterine cervix. Am J Public Health. 1983;73(5):558-62.
25. Cervical Cancer Prevention. Bethesda: National Cancer Institute 2012. http://www.cancer.gov/cancertopics/pdq/prevention/cervical/Patient/ page3#Keypoint5. Accessed 1 Oct 2012.
26. Greenwood GL, Paul JP, Pollack LM, Binson D, Catania JA, Chang J, et al. Tobacco use and cessation among a household-based sample of US urban men who have sex with men. Am J Public Health. 2005;95(1):145-51.
27. Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being. Nicotine Tob Res. 2001;3(3):225-34.
28. Breslau N, Johnson EO. Predicting smoking cessation and major depression in nicotine-dependent smokers. Am J Public Health. 2000;90(7):1122-7.
29. Marks King R, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC. Factors associated with non adherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479-85.
30. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106-10.
31. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on early detection of persons with harmful alcohol consumption-II. Addiction. 1993;88(6):791-804.
32. Boarts JM, Bogart LM, Tabak MA, Armelie AP, Delahanty DL. Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study. J Behav Med. 2008;31:445-51.
33. Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74-81.
34. Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM. Racial differences in virologic failure associated with adherence and quality of life on Efavirenz-containing regimens for initial therapy results of ACTG A5095. J Acquir Immune Defic Syndr. 2007;46(5):547-54.
35. Gonzalez JS, Penedo FJ, Antoni MH, Duran RE, McPherson-Baker S, Ironson G, et al. Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychol. 2004;23(4):413-8.
36. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the ACCTG Adherence Instruments. AIDS Care. 2000;12(2):255-66.
37. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385-96.
38. Cohen S, Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse. Health Psychol. 1990;9(4):466-78.
39. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271-83.
40. Spielberger C, Gorsuch R, Lushene R. STAI Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970.
41. Smith RC, Lay CD. State and trait anxiety: an annotated bibliography. Psychol Rep. (Bibliography Rev). 1974;34(2):519-94.
42. Radloff LS. The CES-D scale: A self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
43. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4):376-86 Quiz 87-89.
44. Brewer NT, Weinstein ND, Cuite CL, Herrington JE. Risk perceptions and their relation to risk behavior. Ann Behav Med. [Research Support, Non-U.S. Gov't]. 2004;27(2):125-30.
45. Weinstein ND. Accuracy of smokers' risk perceptions. Ann Behav Med. 1998;20(2):135-40.
46. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res. 1997;6(6):531-54.
47. Remor E. Psychometric properties of a European Spanish version of the perceived stress scale (PSS). Span J Psychol. 2006;9(1):86-93.
48. Cohen S, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: Theory, research, and applications. The Hague, The Netherlands: Martinus Nijhoff; 1985. p. 73-94.
49. Williams DR, Yu Y, Jackson JS, Anderson NB. Racial differences in physical and mental health. J Health Psychol. 1997;2(3):335-51.
50. Reynolds NR, Neidig JL, Wu AW, Gifford AL, Holmes WC. Balancing disfigurement and fear of disease progression: patient perceptions of HIV body fat redistribution. AIDS Care. 2006;18(7):663-73.
51. Zaragoza-Macias E, Cosco D, Nguyen ML, Del Rio C, Lennox J. Predictors of success with highly active antiretroviral therapy in an antiretroviral-naive urban population. AIDS Res Hum Retrovir. [Research Support, N.I.H., Extramural]. 2010;26(2):133-8.
52. Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2(3):261-70.
53. Cinciripini PM, C. G. Development and validation of a coping skills scale for smoking cessation. Society for Research on Nicotine and Tobacco Annual Meeting; Washington, DC1996.
54. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ, Van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: differences between high- and low-anxiety smokers. J Clin Psychopharmacol. 1995;15(3):182-91.
55. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119-27.
56. HIV among Women. Atlanta: Centers for Disease Control and Prevention; 2011. http://www.cdc.gov/hiv/topics/women/index.htm. Accessed 1 Oct 2012.
57. Erlen JA, Sereika SM, Cook RL, Hunt SC. Adherence to antiretroviral therapy among women with HIV infection. J Obstet Gynecol Neonatal Nurs. 2002;31(4):470-7.
58. Raveis VH, Karus DG, Siegel K. Correlates of depressive symptomatology among adult daughter caregivers of a parent with cancer. Cancer. 1998;83(8):1652-63.
59. Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J, et al. Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998;17(3):253-61.
60. Tufts KA, Wessell J, Kearney T. Self-care behaviors of African American women living with HIV: a qualitative perspective. J Assoc Nurses AIDS Care. 2010;21(1):36-52.
61. Kempf MC, McLeod J, Boehme AK, Walcott MW, Wright L, Seal P, et al. A qualitative study of the barriers and facilitators to retention-in-care among HIV-positive women in the rural southeastern United States: implications for targeted interventions. AIDS Patient Care STDS. 2010;24(8):515-20.
62. Moneyham L, McLeod J, Boehme A, Wright L, Mugavero M, Seal P, et al. Perceived barriers to HIV care among HIV-infected women in the Deep South. J Assoc Nurses AIDS Care. 2010;21(6):467-77.
63. Shubert V, Bernstine N. Moving from fact to policy: housing is HIV prevention and health care. AIDS Behav. 2007;11(6 Suppl):172-81.
64. Watkins-Hayes C, Pittman-Gay L, Beaman J. 'Dying from' to 'living with': framing institutions and the coping processes of African American women living with HIV/AIDS. Soc Sci Med. 2012;74(12):2028-36.
65. Cohen DA, Scribner RA, Farley TA. A structural model of health behavior: a pragmatic approach to explain and influence health behaviors at the population level. Prev Med. 2000;30(2):146-54.
66. Blankenship KM, Friedman SR, Dworkin S, Mantell JE. Structural interventions: concepts, challenges and opportunities for research. J Urban Health. 2006;83(1):59-72.
67. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol. 2012;137(4):516-42.
68. MacLaughlan SD, Lachance JA, Gjelsvik A. Correlation between smoking status and cervical cancer screening: a cross-sectional study. J Low Genit Tract Dis. 2011;15(2):114-9.
69. Coughlin SS, Uhler RJ, Hall HI, Briss PA. Nonadherence to breast and cervical cancer screening: what are the linkages to chronic disease risk? Prev Chronic Dis. 2004;1(1):A04.
70. Simoes EJ, Newschaffer CJ, Hagdrup N, Ali-Abarghoui F, Tao X, Mack N, et al. Predictors of compliance with recommended cervical cancer screening schedule: a population-based study. J Community Health. 1999;24(2):115-30.
71. Byrne MM, Davila EP, Zhao W, Parker D, Hooper MW, Caban-Martinez A, et al. Cancer screening behaviors among smokers and non-smokers. Cancer Epidemiol. 2010;34(5):611-7.
72. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006;96(6):1060-5.
73. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731-6.
74. Webb MS, Vanable PA, Carey MP, Blair DC. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms. AIDS Educ Prev. 2009;21(3 Suppl):94-105.
75. King RM, Vidrine DJ, Danysh HE, Fletcher FE, McCurdy S, Arduino RC, et al. Factors associated with nonadherence to antiretroviral therapy in HIV-positive smokers. AIDS Patient Care STDS. 2012;26(8):479-85.
76. Kendzor DE, Costello TJ, Li Y, Vidrine JI, Mazas CA, Reitzel LR, et al. Race/ethnicity and multiple cancer risk factors among individuals seeking smoking cessation treatment. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2937-45.
77. Faeh D, Viswanathan B, Chiolero A, Warren W, Bovet P. Clustering of smoking, alcohol drinking and cannabis use in adolescents in a rapidly developing country. BMC Public Health. 2006;6:169.
78. Emmons KM, Marcus BH, Linnan L, Rossi JS, Abrams DB. Mechanisms in multiple risk factor interventions: smoking, physical activity, and dietary fat intake among manufacturing workers. Working Well Research Group. Prev Med. 1994;23(4):481-9.
79. Peek ME, Sayad JV, Markwardt R. Fear, fatalism and breast cancer screening in low-income African-American women: the role of clinicians and the health care system. J Gen Intern Med. 2008;23(11):1847-53.
80. Borrelli B, Hayes RB, Dunsiger S, Fava JL. Risk perception and smoking behavior in medically ill smokers: a prospective study. Addiction. 2010;105(6):1100-8.
81. Drew EM, Schoenberg NE. Deconstructing fatalism: ethnographic perspectives on women's decision making about cancer prevention and treatment. Med Anthropol Q. 2011;25(2):164-82.
82. Glasgow RE, Orleans CT, Wagner EH. Does the chronic care model serve also as a template for improving prevention? Milbank Q. 2001;79(4):579-612 IV-V.
83. Goldstein MG, Whitlock EP, DePue J. Multiple behavioral risk factor interventions in primary care: Summary of research evidence. Am J Prev Med. 2004;27(2 Supplement):61-79.
84. Summary Health Statistics for U.S. Adults: National Health Interview Survey. Atlanta: Georgia Centers for Disease Control and Prevention; 2010. http://www.cdc.gov/nchs/data/series/sr-10/sr10-252.pdf. Accessed 1 Nov 2012.
85. Drach L, Holbert T, Maher J, Fox V, Schubert S, Saddler LC. Integrating smoking cessation into HIV care. AIDS Patient Care STDS. 2010;24(3):139-40.
86. Nahvi S, Cooperman NA. Review: the need for smoking cessation among HIV-positive smokers. AIDS Educ Prev. 2009;21(3 Suppl):14-27.